Literature DB >> 11736935

MCP-1 modulates chemotaxis by follicular lymphoma cells.

H Husson1, E G Carideo, A A Cardoso, S M Lugli, D Neuberg, O Munoz, L de Leval, J Schultze, A S Freedman.   

Abstract

The localization and establishment of follicular lymphoma (FL) cells in distinct anatomic sites probably involves chemokine and adhesion receptors on the neoplastic cells and appropriate chemokines and adhesion receptor ligands in the microenvironment. Several chemokines play an important role in normal B-cell trafficking and differentiation. Monocyte chemoattractant protein-1 (MCP-1) is a C-C chemokine that induces chemotaxis of a variety of lymphoid cells through its receptor CCR2. CCR2 is also expressed on B cells, and MCP-1 induces chemotaxis of normal B cells. In this report, we investigated expression and function of CCR2 on FL cells. We found FL cells as well as the t(14; 18)+ B-cell lymphoma line H2 expressed CCR2. MCP-1 potentiated SDF-1-induced chemotaxis of FL cells and H2 cells, but MCP-1 alone did not induce chemotaxis. The specificity of the effects of MCP-1 and SDF-1 was demonstrated by antibody blocking studies. Because FL cells are generally associated with follicular dendritic cells (FDCs), FDCs may be an important source of chemokines. We found that cultured FDCs produced MCP-1, and this production was enhanced by tumour necrosis factor. These data implicate MCP-1 in the migration and localization of FL cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736935     DOI: 10.1046/j.1365-2141.2001.03145.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1alpha as mast cell chemoattractants.

Authors:  Catherine Guettier; Pierre Validire; Dominique Emilie; Viviane Tricottet; Mylène Sebagh; Aurora Anjo; Jean-Louis Misset; Michel Reynes
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

2.  Inflammation, the microenvironment and chronic lymphocytic leukemia.

Authors:  Federico Caligaris-Cappio
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

Review 3.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

4.  Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma.

Authors:  Toni Valković; Antica Duletić-Načinović; Sanja Stifter; Milena Hasan; Ita Hadžisejdić; David Zombori; Blaženka Grahovac; Nives Jonjić
Journal:  Clin Exp Med       Date:  2010-03-16       Impact factor: 3.984

5.  Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling.

Authors:  David A Margolin; Jennifer Silinsky; Chelsea Grimes; Nakia Spencer; Melissa Aycock; Heather Green; Jose Cordova; Nancy K Davis; Tiffany Driscoll; Li Li
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

6.  Gene selection using iterative feature elimination random forests for survival outcomes.

Authors:  Herbert Pang; Stephen L George; Ken Hui; Tiejun Tong
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2012 Sep-Oct       Impact factor: 3.710

7.  HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration.

Authors:  Xiaoqing Lu; Jun Chen; Raquel Malumbres; Elena Cubedo Gil; David M Helfman; Izidore S Lossos
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

8.  Cancer stem cell and stromal microenvironment.

Authors:  Li Li; John Cole; David A Margolin
Journal:  Ochsner J       Date:  2013

9.  Platelet-activating factor antagonists decrease follicular dendritic-cell stimulation of human B lymphocytes.

Authors:  Isaac Halickman; Yolande Bastien; Qianli Zhuang; Monty B Mazer; Baruch Toledano; Bruce D Mazer
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

10.  Screening of key genes associated with R‑CHOP immunochemotherapy and construction of a prognostic risk model in diffuse large B‑cell lymphoma.

Authors:  Ran Liu; Zhi Chen; Shujun Wang; Gang Zhao; Yan Gu; Qi Han; Baoan Chen
Journal:  Mol Med Rep       Date:  2019-08-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.